HomeCompareEMBT vs EPRT

EMBT vs EPRT: Dividend Comparison 2026

EMBT yields 2000000.06% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMBT wins by $4.8792278646347776e+39M in total portfolio value
10 years
EMBT
EMBT
● Live price
2000000.06%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.8792278646347776e+39M
Annual income
$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00
Full EMBT calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — EMBT vs EPRT

📍 EMBT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMBTEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMBT + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMBT pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMBT
Annual income on $10K today (after 15% tax)
$170,000,005.10/yr
After 10yr DRIP, annual income (after tax)
$4,146,935,802,432,179,400,000,000,000,000,000,000,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EMBT beats the other by $4,146,935,802,432,179,400,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMBT + EPRT for your $10,000?

EMBT: 50%EPRT: 50%
100% EPRT50/50100% EMBT
Portfolio after 10yr
$2.4396139323173888e+39M
Annual income
$2,439,374,001,430,694,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

EMBT
No analyst data
Altman Z
-1935.4
Piotroski
1/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMBT buys
0
EPRT buys
0
No recent congressional trades found for EMBT or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMBTEPRT
Forward yield2000000.06%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$4.8792278646347776e+39M$63.4K
Annual income after 10y$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00$12,840.73
Total dividends collected$4.8791964691115763e+39M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: EMBT vs EPRT ($10,000, DRIP)

YearEMBT PortfolioEMBT Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$200,010,706$200,000,006.00$11,205$505.18+$200.00MEMBT
2$3,738,731,992,770$3,738,517,981,314.42$12,672$682.46+$3738731.98MEMBT
3$65,315,068,744,949,500$65,311,068,301,717,240.00$14,490$930.48+$65315068744.94MEMBT
4$1,066,400,958,023,135,400,000$1,066,331,070,899,578,300,000.00$16,786$1,282.69+$1066400958023135.38MEMBT
5$16,272,185,237,131,282,000,000,000$16,271,044,188,106,197,000,000,000.00$19,753$1,791.56+$16272185237131282432.00MEMBT
6$232,054,281,880,765,440,000,000,000,000$232,036,870,642,561,700,000,000,000,000.00$23,677$2,541.64+$2.3205428188076545e+23MEMBT
7$3,092,799,715,549,616,000,000,000,000,000,000$3,092,551,417,468,003,600,000,000,000,000,000.00$29,008$3,672.99+$3.0927997155496157e+27MEMBT
8$38,524,114,942,504,994,000,000,000,000,000,000,000$38,520,805,646,809,356,000,000,000,000,000,000,000.00$36,463$5,425.08+$3.8524114942504996e+31MEMBT
9$448,468,947,092,778,960,000,000,000,000,000,000,000,000$448,427,726,289,790,500,000,000,000,000,000,000,000,000.00$47,238$8,221.57+$4.4846894709277894e+35MEMBT
10$4,879,227,864,634,777,500,000,000,000,000,000,000,000,000,000$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00$63,385$12,840.73+$4.8792278646347776e+39MEMBT

EMBT vs EPRT: Complete Analysis 2026

EMBTStock

Ember Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The company focuses on the clinical application of bone morphogenetic protein-7 (BMP-7) to develop regenerative medicines for the disease modification of osteoarthritis (OA), reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases, such as chronic kidney disease (CKD) and Alport's syndrome, as well as metabolic diseases, including obesity and type 2 diabetes. Its lead BMP-7 product candidates include MT-006, which has completed Phase 2a clinical trial for targeting OA; MT-007 that has completed Preclinical trial for CKD and Alport syndrome; MT-008, a Preclinical trial completed candidate for Alport syndrome; and MT-009, a Preclinical trial completed candidate for metabolic disease. The company also holds approximately 450 patents covering BMP-7 and its related family of BMPs, variants, novel formulations, delivery technologies, associated clinical data, and manufactured material with current good manufacturing practice. Ember Therapeutics, Inc. was founded in 2010 and is headquartered in New York, New York.

Full EMBT Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this EMBT vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMBT vs SCHDEMBT vs JEPIEMBT vs OEMBT vs KOEMBT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.